Skip to main navigation Skip to search Skip to main content

Ovarian cancer - Can intraperitoneal therapy be regarded as new standard in Germany?

  • Dr. Horst-Schmidt-Klinik
  • Evangelisches Krankenhaus Düsseldorf
  • Charité – Universitätsmedizin Berlin
  • University Hospital Schleswig-Holstein

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

The German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) and the two German cooperative study groups (AGO-OVAR and NOGGO) performed a review of the currently available literature on intraperitoneal first-line treatment in advanced ovarian cancer to consider if this new option should be incorporated into the German guidelines for treatment of ovarian cancer.

Original languageEnglish
Pages (from-to)1756-1760
Number of pages5
JournalInternational Journal of Gynecological Cancer
Volume16
Issue number5
DOIs
StatePublished - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Guidelines
  • Intraperitoneal therapy
  • Ovarian cancer
  • Paclitaxel
  • Platinum

Fingerprint

Dive into the research topics of 'Ovarian cancer - Can intraperitoneal therapy be regarded as new standard in Germany?'. Together they form a unique fingerprint.

Cite this